Physician profile
Sachin Gupta
NPI 1306953104
$24,713.86
in general payments reported to CMS, 2019-2025
18 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $5,057 · 2021: $189 · 2022: $341 · 2023: $1,367 · 2024: $161 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010 · Travel and Lodging: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.68 |
| Travel and Lodging | $741.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $22,151.36 | 2019-2020 | |
| Novocure INC. | $1,171.72 | 2023 | |
| Glaxosmithkline, LLC. | $411.48 | 2020-2024 | Zejula, Jemperli |
| Abbott Laboratories | $167.48 | 2020 | |
| Boston Scientific Corporation | $108.70 | 2022-2025 | Cds - Mct/Cem Monitoring |
| Novartis Pharmaceuticals Corporation | $107.64 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $99.03 | 2022 | |
| Merck Sharp & Dohme LLC | $93.55 | 2021-2023 | Verquvo |
| Cvrx, INC. | $86.83 | 2024-2025 | Barostim Neo System |
| Amgen INC. | $67.79 | 2025 | Repatha |
| Pfizer INC. | $51.26 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $50.41 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.54 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $32.42 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $22.73 | 2024 | Uptravi, Opsumit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $17.50 | 2019 | |
| Siemens Medical Solutions USA, INC. | $16.20 | 2019 | |
| Amarin Pharma, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachin Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.